Chris Takimoto
Chief Tech/Sci/R&D Officer chez IGM BIOSCIENCES, INC.
Fortune : 1 M $ au 29/02/2024
Profil
Chris H.
Takimoto is Chief Medical Officer at IGM Biosciences, Inc.
In the past Dr. Takimoto held the position of Senior Vice President-Oncology at Gilead Sciences, Inc. and Chief Medical Officer for Forty Seven, Inc. (a subsidiary of Gilead Sciences, Inc.), Senior Director-Translational Medicine at Ortho Biotech Oncology Research & Development, VP-Experimental Medicine Early Development at Janssen Global Services LLC and Associate Professor at the University of Texas Health Science Center At San Antonio.
Chris H.
Takimoto received an undergraduate degree from Stanford University, a doctorate from Yale University and a doctorate from Yale School of Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
IGM BIOSCIENCES, INC.
0,29% | 14/03/2024 | 94 388 ( 0,29% ) | 1 M $ | 29/02/2024 |
Postes actifs de Chris Takimoto
Sociétés | Poste | Début |
---|---|---|
IGM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 29/07/2021 |
Anciens postes connus de Chris Takimoto
Sociétés | Poste | Fin |
---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2021 |
FORTY SEVEN, INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01/01/2016 |
Ortho Biotech Oncology Research & Development | Corporate Officer/Principal | 01/01/2010 |
University of Texas Health Science Center At San Antonio | Corporate Officer/Principal | - |
Formation de Chris Takimoto
Stanford University | Undergraduate Degree |
Yale University | Doctorate Degree |
Yale School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
IGM Biosciences, Inc. | |
Ortho Biotech Oncology Research & Development | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |